Skip to main content
Top
Published in: Acta Diabetologica 3/2014

01-06-2014 | Short Communication

Diagnosis of type 1 diabetes within the first five years of life influences quality of life and risk of severe hypoglycemia in adulthood

Authors: M. Trento, M. Trevisan, E. Coppo, A. Raviolo, M. M. Zanone, F. Cavallo, M. Porta

Published in: Acta Diabetologica | Issue 3/2014

Login to get access

Abstract

Progressive adaptation to disease is paramount to improve quality of life (QoL) and other psychological dimensions in type 1 diabetes (T1DM). This study aimed at identifying possible correlations between QoL, locus of control (LoC) and clinical variables in patients with T1DM followed up for 16 years. Fifty-nine patients (27 women) with T1DM, part of a cohort of 112 followed since 1996, accepted to participate. Patients were divided into those in whom onset of T1DM had been during the first 5 years of life (n = 16) or later. They were also stratified into worsened, stable and improved, based on whether their HbA1c had increased/decreased by 1 percentage point between baseline and last follow-up visit. QoL was measured by the Diabetes Quality of Life questionnaire (DQOL), translated into Italian and re-validated. The LoC was measured by the Peyrot- and Rubin-specific questionnaire. Patients who developed T1DM before age 5 had a better total DQOL score than those who developed it later in life, mainly due to the satisfaction dimension and a tendency to decreased fatalism in adult age. All subjects whose HbA1c had worsened from baseline had had their diagnosis after age 5 and reported more frequent episodes of hypoglycemia. Onset of diabetes after age 5 and more frequent hypoglycemia was more likely in subjects with worsened HbA1c (ORs 7.6, p < 0.10 and 20.3, p < 0.01, respectively, from a multivariate logistic model with HbA1c, dichotomized in ‘worsened’ vs all others, as dependent variable). Onset of T1DM during the first 5 years of life may result in better QoL and less fatalism in the long term. Presumably, these patients have no memory of disease onset, which may reduce trauma and facilitate adaptation to managing life with diabetes.
Literature
2.
go back to reference The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977e86 The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977e86
3.
go back to reference Mannucci E, Mezzani B, Conti A, Rotella CM (1994) Valutazione della qualità della vita nei pazienti adulti diabetici di tipo I. Il Diabete 6:223–228 Mannucci E, Mezzani B, Conti A, Rotella CM (1994) Valutazione della qualità della vita nei pazienti adulti diabetici di tipo I. Il Diabete 6:223–228
4.
go back to reference Trento M, Tomelini M, Basile M, Borgo E, Passera P, Miselli V, Tomalino M, Cavallo F, Porta M (2008) The locus of control in patients with type 1 and type 2 diabetes managed by individual and group care. Diabet Med 25:86–90PubMedCrossRef Trento M, Tomelini M, Basile M, Borgo E, Passera P, Miselli V, Tomalino M, Cavallo F, Porta M (2008) The locus of control in patients with type 1 and type 2 diabetes managed by individual and group care. Diabet Med 25:86–90PubMedCrossRef
5.
go back to reference Sánchez JC, Loredo JC (2009) Constructivisms from a genetic point of view: a critical classification of current tendencies. Integr Psychol Behav Sci 43:332–349PubMedCrossRef Sánchez JC, Loredo JC (2009) Constructivisms from a genetic point of view: a critical classification of current tendencies. Integr Psychol Behav Sci 43:332–349PubMedCrossRef
Metadata
Title
Diagnosis of type 1 diabetes within the first five years of life influences quality of life and risk of severe hypoglycemia in adulthood
Authors
M. Trento
M. Trevisan
E. Coppo
A. Raviolo
M. M. Zanone
F. Cavallo
M. Porta
Publication date
01-06-2014
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2014
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0530-6

Other articles of this Issue 3/2014

Acta Diabetologica 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.